title: Front-line erlotinib in unselected patients with advanced NSCLC and poor performance status - the TOPICAL study.
authors: Breakthrough Cancer Research Unit, Pangaea Biotech, Dexeus University Institute, Barcelona, Spain ;
authors: Niki
authors: N
authors: Karachaliou
authors: Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China ;
authors: Jia
authors: J
authors: Wei
authors: Medical Oncology Department, Hospital de Braga, Portugal ;
authors: Ana Daniela
authors: AD
authors: Marques
authors: Breakthrough Cancer Research Unit, Pangaea Biotech, Dexeus University Institute, Barcelona, Spain ; ; Catalan Institute of Oncology, Badalona, Spain.
authors: Rafael
authors: R
authors: Rosell